Minerva Neurosciences logo

Minerva Neurosciences Share Price Today

(NASDAQ: NERV)

Minerva Neurosciences share price is $1.66 & ₹144.37 as on 6 Mar 2025, 2.30 'hrs' IST

$1.66

0.08

(5.06%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Minerva Neurosciences share price in Dollar and Rupees. Guide to invest in Minerva Neurosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Minerva Neurosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Minerva Neurosciences share price movements

  • Today's Low: $1.53
    Today's High: $1.80

    Day's Volatility :15.0%

  • 52 Weeks Low: $1.53
    52 Weeks High: $3.69

    52 Weeks Volatility :58.54%

Minerva Neurosciences (NERV) Returns

PeriodMinerva Neurosciences, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-25.47%
2.1%
0.0%
6 Months
-39.0%
-4.1%
0.0%
1 Year
-39.23%
2.2%
0.0%
3 Years
-68.86%
11.8%
-11.6%

Minerva Neurosciences (NERV) Key Statistics

in dollars & INR

Previous Close
$1.58
Open
$1.58
Today's High
$1.8
Today's Low
$1.53
Market Capitalization
$11.7M
Today's Volume
$3.1K
52 Week High
$3.69
52 Week Low
$1.53
Revenue TTM
$0.0
EBITDA
$-21.8M
Earnings Per Share (EPS)
$0.17
PE Ratio
9.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-675.09%

How to invest in Minerva Neurosciences Stock (NERV) from India?

It is very easy for Indian residents to invest directly in Minerva Neurosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Minerva Neurosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Minerva Neurosciences or NERV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Minerva Neurosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Minerva Neurosciences shares which would translate to 0.524 fractional shares of Minerva Neurosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Minerva Neurosciences, in just a few clicks!

Returns in Minerva Neurosciences (NERV) for Indian investors in Rupees

The Minerva Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Minerva Neurosciences investment value today

Current value as on today

₹68,809

Returns

₹31,191

(-31.19%)

Returns from Minerva Neurosciences Stock

₹36,154 (-36.15%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Minerva Neurosciences (NERV)

6%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Minerva Neurosciences Stock from India on INDmoney has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Minerva Neurosciences

  • Federated Hermes Inc

    19.32%

  • Vanguard Group Inc

    3.60%

  • Renaissance Technologies Corp

    1.83%

  • UBS O'Connor LLC

    1.53%

  • BlackRock Inc

    1.04%

  • Geode Capital Management, LLC

    0.81%

Analyst Recommendation on Minerva Neurosciences

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Minerva Neurosciences(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Minerva Neurosciences Stock (NERV)

What analysts predicted

Upside of 201.2%

Target:

$5.00

Current:

$1.66

Insights on Minerva Neurosciences Stock (Ticker Symbol: NERV)

  • Price Movement

    In the last 1 month, NERV stock has moved down by -33.6%
  • NERV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 101.5%
  • NERV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 118.2%

Minerva Neurosciences Technicals Summary

Sell

Neutral

Buy

Minerva Neurosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Minerva Neurosciences (NERV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Minerva Neurosciences, Inc. logo
-29.93%
-39.0%
-39.23%
-68.86%
-97.26%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Minerva Neurosciences, Inc. logo
9.0
9.0
0.0
-2.68
-6.75
-0.29
NA
-3.67
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Minerva Neurosciences, Inc. logo
Sell
$11.7M
-97.26%
9.0
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Minerva Neurosciences

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Organization
Minerva Neurosciences
Employees
8
CEO
Dr. Remy Luthringer Ph.D.
Industry
Health Technology

Management People of Minerva Neurosciences

NameTitle
Dr. Remy Luthringer Ph.D.
Executive Chairman & CEO
Mr. Geoffrey Robin Race F.C.M.A., M.B.A.
President
Mr. Frederick W. Ahlholm CPA
Senior VP, CFO & Secretary
Mr. Joseph Reilly
Senior VP & COO
Mr. William B. Boni
Vice President of Investor Relations & Corporate Communications
Prof. Michael Davidson M.D.
Chief Medical Officer

Important FAQs about investing in NERV Stock from India :

What is Minerva Neurosciences share price today?

Minerva Neurosciences share price today stands at $1.66, Open: $1.58 ; Previous Close: $1.58 ; High: $1.80 ; Low: $1.53 ; 52 Week High: $3.69 ; 52 Week Low: $1.53.

The stock opens at $1.58, after a previous close of $1.58. The stock reached a daily high of $1.80 and a low of $1.53, with a 52-week high of $3.69 and a 52-week low of $1.53.

Can Indians buy Minerva Neurosciences shares?

Yes, Indians can invest in the Minerva Neurosciences (NERV) from India.

With INDmoney, you can buy Minerva Neurosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Minerva Neurosciences at zero transaction cost.

How can I buy Minerva Neurosciences shares from India?

It is very easy to buy Minerva Neurosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Minerva Neurosciences (NERV) be purchased?

Yes, you can buy fractional shares of Minerva Neurosciences with INDmoney app.

What are the documents required to start investing in Minerva Neurosciences stocks?

To start investing in Minerva Neurosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Minerva Neurosciences Stock (NERV)?

Today’s highest price of Minerva Neurosciences (NERV) is $1.80.

Today’s lowest price of Minerva Neurosciences (NERV) is $1.53.

What is today's market capitalisation of Minerva Neurosciences?

Today's market capitalisation of Minerva Neurosciences NERV is 11.7M

What is the 52 Week High and Low Range of Minerva Neurosciences Stock (NERV)?

  • 52 Week High

    $3.69

  • 52 Week Low

    $1.53

What are the historical returns of Minerva Neurosciences (NERV)?

  • 1 Month Returns

    -29.93%

  • 3 Months Returns

    -39%

  • 1 Year Returns

    -39.23%

  • 5 Years Returns

    -97.26%

Who is the Chief Executive Officer (CEO) of Minerva Neurosciences ?

Dr. Remy Luthringer Ph.D. is the current Chief Executive Officer (CEO) of Minerva Neurosciences.